CLIMVIB at 15th edition of the European Meeting on HIV & Hepatitis in Rome

We are pleased to announce that CLIMVIB will be participating to the 15th edition of the European Meeting on HIV & Hepatitis – Treatment Strategies & Anviral Drug Resistance,  to be held 7 – 9 June 2017 at the Roma Eventi – Fontana di Trevi Conference Centre in Rome, Italy.

“The European HIV and Hepatitis meeting was started 15 years ago with the objective to provide infectious disease clinicians and clinical virologists involved in antiviral clinical practice and research with an opportunity to share data and discuss their clinical application.” The meeting has now become “the premier European platform for clinicians and clinical virologists to discuss the latest developments in antiviral therapy for HIV, HCV and HBV and for translating them into new treatment strategies to further improve clinical care”.

We are proud to inform our readers that Dr. Valeria Micheli, Adjunct professor at University of Milan, who is responsible for the molecular diagnosis of viral hepatitis and the study of drug-resistance of HIV, HBV and HCV, as well as HIV tropism at CLIMVIB, will contribute to the meeting with her work “HIV Genotypic Drug Resistance test (GRT) for Integrase Strand Stranfer Inhibitors (INSTIs) at low level viremia: light and shadow in the clinical practice”.

CLIMVIB team wish to thank the organizers for inviting us to share our experience and expertise at such a valuable meeting of experts. For more information on the event please refer to the EUROPEAN MEETING ON HIV & HEPATITIS official web site.

Comments are closed